妇科管理乳腺癌幸存者。
Gynecological management of the breast cancer survivor.
机构信息
University of California, San Francisco School of Medicine, 533 Parnassus Avenue, San Francisco, CA, 94143, USA.
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, 2356 Sutter Street, San Francisco, CA, 94143, USA.
出版信息
Best Pract Res Clin Obstet Gynaecol. 2022 Jun;82:69-80. doi: 10.1016/j.bpobgyn.2022.01.013. Epub 2022 Feb 16.
Survival from breast cancer has continued to increase since the 1990's, and quality of life and gynecologic issues have been an increasingly important part of overall care. Common women's health issues such as contraception, pregnancy, menopause, and sexual functioning are uniquely affected by breast cancer diagnosis and treatment. Two-thirds of breast cancers are hormone-sensitive and adjuvant hormonal therapies like tamoxifen or aromatase inhibitors have substantially decreased the disease recurrence and contralateral breast cancer. These hormonal therapies can cause menopausal and sexual side effects, and women's healthcare providers need to understand safe and effective treatment options to manage them. Providing counseling and evidence-based education is important for primary care providers and gynecologists who care for those women who have or previously had breast cancer. This review will focus on specific women's health issues pertaining to breast cancer and treatment.
自 20 世纪 90 年代以来,乳腺癌患者的生存率持续提高,生活质量和妇科问题已成为整体护理中越来越重要的一部分。避孕、怀孕、绝经和性功能等常见的女性健康问题会因乳腺癌的诊断和治疗而受到独特的影响。三分之二的乳腺癌对激素敏感,辅助激素疗法(如他莫昔芬或芳香酶抑制剂)大大降低了疾病复发和对侧乳腺癌的风险。这些激素疗法会引起绝经和性功能副作用,女性保健提供者需要了解安全有效的治疗选择来进行管理。为那些患有或曾患有乳腺癌的女性提供咨询和基于证据的教育对初级保健提供者和妇科医生非常重要。这篇综述将重点介绍与乳腺癌和治疗相关的特定女性健康问题。